Zhou L - Search Results

1

Bifidobacterium infantis Induces Protective Colonic PD-L1 and Foxp3 Regulatory T Cells in an Acute Murine Experimental Model of Inflammatory Bowel Disease.

Zhou L, Liu D, Xie Y, Yao X, Li Y. Zhou L, et al. Gut Liver. 2019 Mar 15;13(4):430-439. doi: 10.5009/gnl18316. Gut Liver. 2019. PMID: 30600673 Free PMC article.

2

Bifidobacterium infantis regulates the programmed cell death 1 pathway and immune response in mice with inflammatory bowel disease.

Zhou LY, Xie Y, Li Y. Zhou LY, et al. World J Gastroenterol. 2022 Jul 14;28(26):3164-3176. doi: 10.3748/wjg.v28.i26.3164. World J Gastroenterol. 2022. PMID: 36051332 Free PMC article.

3

Protective Effects of Clostridium Butyricum in a Murine Model of Dextran Sodium Sulfate-Induced Colitis That Involve Inhibition of the TLR2 Signaling Pathway and T Helper 17 Cells.

Xie Y, Zhou L, Yao X, Li Y. Xie Y, et al. Among authors: zhou l. Am J Med Sci. 2020 Aug;360(2):176-191. doi: 10.1016/j.amjms.2020.05.021. Epub 2020 May 20. Am J Med Sci. 2020. PMID: 32553747

4

Bifidobacterium infantis Promotes Foxp3 Expression in Colon Cells via PD-L1-Mediated Inhibition of the PI3K-Akt-mTOR Signaling Pathway.

Zhou L, Xie Y, Li Y. Zhou L, et al. Front Immunol. 2022 Jul 4;13:871705. doi: 10.3389/fimmu.2022.871705. eCollection 2022. Front Immunol. 2022. PMID: 35860248 Free PMC article.

5

FAM60A, increased by Helicobacter pylori, promotes proliferation and suppresses apoptosis of gastric cancer cells by targeting the PI3K/AKT pathway.

Yao X, Liu D, Zhou L, Xie Y, Li Y. Yao X, et al. Among authors: zhou l. Biochem Biophys Res Commun. 2020 Jan 22;521(4):1003-1009. doi: 10.1016/j.bbrc.2019.11.029. Epub 2019 Nov 12. Biochem Biophys Res Commun. 2020. PMID: 31727367

6

Clostridium butyricum Supernatant Regulates the Expression of RORγt in HCT-116 Cells by Inhibiting the TLR2/MyD88/NF-κB Signaling Pathway.

Xie Y, Zhou L, Li H, Li Y. Xie Y, et al. Among authors: zhou l. Curr Microbiol. 2021 Apr;78(4):1543-1550. doi: 10.1007/s00284-021-02392-1. Epub 2021 Mar 6. Curr Microbiol. 2021. PMID: 33675405

7

A Case of Vedolizumab-induced Acute Allergic Reaction in a Patient With Refractory Ulcerative Colitis.

Xie Y, Li H, Zhou L, Tian F. Xie Y, et al. Among authors: zhou l. Inflamm Bowel Dis. 2022 Jul 1;28(7):e103. doi: 10.1093/ibd/izac008. Inflamm Bowel Dis. 2022. PMID: 35134937 No abstract available.

8

Idiopathic Myointimal Hyperplasia of the Mesenteric Veins: A Case Report.

Zhou L, Tian F, Zhang H, Shu H, Gao Y, Cui M, Xie Y. Zhou L, et al. Inflamm Bowel Dis. 2022 Sep 1;28(9):e131-e133. doi: 10.1093/ibd/izac113. Inflamm Bowel Dis. 2022. PMID: 35639934 No abstract available.

9

Hepatobiliary and Pancreatic: Management of bleeding colonic varices in liver disease.

Zhou LY, Ma YJ, Tian F. Zhou LY, et al. J Gastroenterol Hepatol. 2017 Dec;32(12):1913. doi: 10.1111/jgh.13988. J Gastroenterol Hepatol. 2017. PMID: 29125212 No abstract available.

10

Roadmap to discovery and early development of an mRNA loaded LNP formulation for liver therapeutic genome editing.

Bak A, Zhou L, Rejman J, Yanez Arteta M, Nilsson G, Ashford M. Bak A, et al. Among authors: zhou l. Expert Opin Drug Deliv. 2025 Jan 11. doi: 10.1080/17425247.2025.2452295. Online ahead of print. Expert Opin Drug Deliv. 2025. PMID: 39797693 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33,711 results

Search Page

Filters